LCN2 and breast carcinoma: Researches indicated that LCN2 exerts a crucial influence on the progression of breast cancer brain metastasis through diverse mechanisms, including enhancement of proliferation and EMT, ECM remodeling and intravasation, disruption of the blood-brain barrier, modulation of the neuroinflammation and immune suppression in brain microenvironment.